Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Gross Margin (2016 - 2026)

Phibro Animal Health has reported Gross Margin over the past 14 years, most recently at 35.48% for Q4 2025.

  • For Q4 2025, Gross Margin rose 254.0% year-over-year to 35.48%; the TTM value through Dec 2025 reached 31.89%, up 6.0%, while the annual FY2025 figure was 30.85%, 9.0% up from the prior year.
  • Gross Margin for Q4 2025 was 35.48% at Phibro Animal Health, up from 32.92% in the prior quarter.
  • Over five years, Gross Margin peaked at 35.48% in Q4 2025 and troughed at 29.05% in Q2 2025.
  • A 5-year average of 31.14% and a median of 30.74% in 2022 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: surged 279bps in 2024 and later crashed -285bps in 2025.
  • Year by year, Gross Margin stood at 30.37% in 2021, then grew by 4bps to 31.63% in 2022, then decreased by -1bps to 31.45% in 2023, then increased by 5bps to 32.94% in 2024, then grew by 8bps to 35.48% in 2025.
  • Business Quant data shows Gross Margin for PAHC at 35.48% in Q4 2025, 32.92% in Q3 2025, and 29.05% in Q2 2025.